Literature DB >> 8795127

Epilepsy in Down syndrome--prevalence in three age groups.

P Johannsen1, J E Christensen, H Goldstein, V K Nielsen, J Mai.   

Abstract

A prevalence study of epilepsy in patients with Down syndrome (n = 85) in three age-groups (14-16 years, 23-29 years, 50-60 years) was conducted in the county of Aarhus, Denmark. Seventy-two patients (85%) participated. An interview and a neurological examination were performed. An EEG was recorded in 50 patients. Twelve patients (17%) had epilepsy. ILAE-1981-classification: two with partial seizures, seven with primary generalized and three with unclassifiable generalized seizures. Two patients with epilepsy had a normal EEG and 13 patients without epilepsy had an abnormal EEG.

Entities:  

Mesh:

Year:  1996        PMID: 8795127

Source DB:  PubMed          Journal:  Seizure        ISSN: 1059-1311            Impact factor:   3.184


  4 in total

1.  Altered distribution of hippocampal interneurons in the murine Down Syndrome model Ts65Dn.

Authors:  Samuel Hernández-González; Raúl Ballestín; Rosa López-Hidalgo; Javier Gilabert-Juan; José Miguel Blasco-Ibáñez; Carlos Crespo; Juan Nácher; Emilio Varea
Journal:  Neurochem Res       Date:  2014-11-16       Impact factor: 3.996

2.  Health conditions associated with aging and end of life of adults with Down syndrome.

Authors:  Anna J Esbensen
Journal:  Int Rev Res Ment Retard       Date:  2010

3.  Epilepsy is overrepresented among young people who died from COVID-19: Analysis of nationwide mortality data in Hungary.

Authors:  Réka A Horváth; Zsófia Sütő; Balázs Cséke; Dániel Schranz; Gergely Darnai; Norbert Kovács; Imre Janszky; József Janszky
Journal:  Seizure       Date:  2021-12-01       Impact factor: 3.184

4.  Trisomy 21 activates the kynurenine pathway via increased dosage of interferon receptors.

Authors:  Rani K Powers; Rachel Culp-Hill; Michael P Ludwig; Keith P Smith; Katherine A Waugh; Ross Minter; Kathryn D Tuttle; Hannah C Lewis; Angela L Rachubinski; Ross E Granrath; María Carmona-Iragui; Rebecca B Wilkerson; Darcy E Kahn; Molishree Joshi; Alberto Lleó; Rafael Blesa; Juan Fortea; Angelo D'Alessandro; James C Costello; Kelly D Sullivan; Joaquin M Espinosa
Journal:  Nat Commun       Date:  2019-10-18       Impact factor: 14.919

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.